Abstract

This study aimed to explore the effects of fucoidan from Fucus vesiculosus on concanavalin A (ConA)-induced acute liver injury in mice. Pretreatment with fucoidan protected liver function indicated by ALT, AST and histopathological changes by suppressing inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ). In addition, intrinsic and extrinsic apoptosis mediated by Bax, Bid, Bcl-2, Bcl-xL and Caspase 3, 8, and 9 were inhibited by fucoidan and the action was associated with the TRADD/TRAF2 and JAK2/STAT1 signal pathways. Our results demonstrated that fucoidan from Fucus vesiculosus alleviated ConA-induced acute liver injury via the inhibition of intrinsic and extrinsic apoptosis mediated by the TRADD/TRAF2 and JAK2/STAT1 pathways which were activated by TNF-α and IFN-γ. These findings could provide a potential powerful therapy for T cell-related hepatitis.

Highlights

  • Liver injury is the basis of acute liver failure

  • Decreased edema and necrosis were noted with increased fucoidan concentration at each time point, which demonstrated that fucoidan pretreatment effectively improved acute injury caused by concanavalin A (ConA) and protected liver cells from damage

  • We demonstrated that fucoidan pretreatment may protect against ConA-induced acute liver injury by inhibiting both intrinsic and extrinsic apoptosis using a well-established model and showed the significance of drug screening for T lymphocyte-dependent injury

Read more

Summary

Introduction

Liver injury is the basis of acute liver failure. Severe and persistent liver damage eventually leads to liver failure. The incidence of autoimmune and viral hepatitis which can develop into cirrhosis and even lead to death has risen sharply. The pathogenesis of these diseases is associated with the cytotoxic effect of sensitized T lymphocytes and pro-inflammatory cytokines produced by endotoxin-stimulated macrophages [2]. Three types of inducers, including concanavalin A (ConA), D-galactosamine (D-GalN)/lipopolysaccharides (LPS) and high dose LPS were used to simulate the pathological processes in acute liver injury. Of these inducers, ConA which is characterized by easy establishment, obvious change in liver enzymes and cytokine

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.